How to appeal a Blue Cross NC cardiac devices & procedures denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Blue Cross NC-specific note: BCBS licensee for North Carolina (~4.3M members). Prime Therapeutics PBM. NC DOI oversight. Blue Premier is the high-profile value-based care program. Recently divested some Medicaid business; Healthy Blue (joint venture with Elevance) handles NC Medicaid.

What Blue Cross NC's policy requires for cardiac devices & procedures

Cited policy: BCBS — Transcatheter Mitral Valve Repair / Anthem clinical guideline TEER

COAPT phenotype: EF 20-50%, severe secondary MR, NYHA II-IVa on GDMT >=3 months, prohibitive surgical risk. Heart Team evaluation per NCD 20.34.

How Blue Cross NC denies cardiac devices & procedures — and how to counter it

Where Blue Cross NC pushes back: 1) Functional MR investigational; 2) EF outside COAPT window (20-50%); 3) GDMT not optimized; 4) Surgical candidate determination unclear.

Counter-arguments that hold up: Demonstrate COAPT phenotype: EF, EROA, regurgitant volume, NYHA, GDMT trial. Cite COAPT NEJM 2018 + NCD 20.34 + 2020/2023 VHD Guideline Class IIa for secondary MR. Heart Team consensus with surgical risk attestation; STS-PROM >=8% or prohibitive risk.

What Blue Cross NC typically denies for cardiac devices & procedures

Across Blue Cross NC's commercial and Medicare books, denials cluster around a small number of patterns. For cardiac devices & procedures, expect:

• Step therapy via Prime Therapeutics
• Blue Premier value-based arrangement disputes
• Out-of-network reductions
• Specialty drug PA

Treatments most often denied in this category

These are the cardiac devices & procedures treatments most often flagged for prior auth, step therapy, or medical necessity review:

• ICD (primary)
• ICD (secondary)
• CRT-D / CRT-P
• Watchman LAAC
• TAVR (high risk)
• TAVR (intermediate)

How to submit the appeal to Blue Cross NC

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Blue Cross NC cited in the denial.
3. File the appeal through Blue Cross NC's portal (members: https://www.bluecrossnc.com ; providers: https://www.bluecrossnc.com/providers). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In NC, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Blue Cross NC's prior-authorization criteria by drug: Blue Cross NC PA criteria on ApprovalHelp.